What Made Maxim Group Downgrade Applied DNA Sciences’ Stock?


In a report released today, Anthony Vendetti from Maxim Group downgraded Applied DNA Sciences (APDN) to Hold. The company’s shares closed on Friday at $0.38, close to its 52-week low of $0.30.

Vendetti noted:

“On December 18, 2018, APDN reported F4Q18 (Sept) revenue and a GAAP loss per share relatively inline with the preannouncement.”

According to TipRanks.com, Vendetti is a 3-star analyst with an average return of 0.5% and a 45.6% success rate. Vendetti covers the Healthcare sector, focusing on stocks such as Restoration Robotics Inc, Xtant Medical Holdings, and Ra Medical Systems Inc.

Applied DNA Sciences has an analyst consensus of Hold.

See today’s analyst top recommended stocks >>

The company has a one-year high of $1.84 and a one-year low of $0.30. Currently, Applied DNA Sciences has an average volume of 270.6K.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Applied DNA Sciences, Inc. engages in the provision of security solutions. It offers molecular-based technology solutions and services that can help protect products, brands, supply chains, and intellectual property of companies, governments, and consumers from theft, counterfeiting, fraud, and diversion.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts